Show simple item record

dc.contributor.authorSmoktunowicz, N
dc.contributor.authorPlaté, M
dc.contributor.authorOrtiz-Stern, A
dc.contributor.authorD'Antongiovanni, V
dc.contributor.authorRobinson, E
dc.contributor.authorChudasama, V
dc.contributor.authorCaddick, S
dc.contributor.authorScotton, CJ
dc.contributor.authorJarai, G
dc.contributor.authorChambers, RC
dc.date.accessioned2016-10-21T11:55:03Z
dc.date.issued2016-08-22
dc.description.abstractThe major high-affinity thrombin receptor, proteinase activated receptor-1 (PAR-1) is expressed at low levels by the normal epithelium but is upregulated in many types of cancer, including lung cancer. The thrombin-PAR-1 signalling axis contributes to the activation of latent TGFβ in response to tissue injury via an αvβ6 integrin-mediated mechanism. TGFβ is a pleiotropic cytokine that acts as a tumour suppressor in normal and dysplastic cells but switches into a tumour promoter in advanced tumours. In this study we demonstrate that TGFβ is a positive regulator of PAR-1 expression in A549 lung adenocarcinoma cells, which in turn increases the sensitivity of these cells to thrombin signalling. We further demonstrate that this effect is Smad3-, ERK1/2- and Sp1-dependent. We also show that TGFβ-mediated PAR-1 upregulation is accompanied by increased expression of integrin αv and β6 subunits. Finally, TGFβ pre-stimulation promotes increased migratory potential of A549 to thrombin. These data have important implications for our understanding of the interplay between coagulation and TGFβ signalling responses in lung cancer.en_GB
dc.description.sponsorshipMedical Research Council UK (MRC) CASE studentship with Novartis awarded to RCC, MRC Centenary Award awarded to NS and RCC, and MRC Career Development Award G0800340 to CJS.en_GB
dc.identifier.citationVol. 7, No. 40, pp. 65471-65484.en_GB
dc.identifier.doi10.18632/oncotarget.11472
dc.identifier.urihttp://hdl.handle.net/10871/24011
dc.language.isoenen_GB
dc.publisherImpact Journalsen_GB
dc.rightsThis is a free access article. Available from Impact Journals via the DOI in this record. Licensed under a Creative Commons Attribution 3.0 License. https://creativecommons.org/licenses/by/3.0/en_GB
dc.subjectPAR-1en_GB
dc.subjectTGFβen_GB
dc.subjectcanceren_GB
dc.subjectthrombinen_GB
dc.titleTGFβ upregulates PAR-1 expression and signalling responses in A549 lung adenocarcinoma cells.en_GB
dc.typeArticleen_GB
dc.date.available2016-10-21T11:55:03Z
dc.identifier.eissn1949-2553
dc.identifier.journalOncotargeten_GB
dc.identifier.pmid27566553


Files in this item

This item appears in the following Collection(s)

Show simple item record